These data evidence a CD28-associated gradual phenotypic change of CD103+PD1+ CD8+ T cells from the periphery, where are mainly CD28+ to the tumor where are mostly enriched of a CD28− phenotype. This evidence concerns the gene CD8A and neoplasm.